BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36007974)

  • 1. Sertoli-Leydig cell ovarian tumour: a rare cause of virilisation and androgenic alopecia.
    Mudraje S; Shetty S; Guruvare S; Kudva R
    BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 36007974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virilising ovarian tumour in a woman with an adrenal nodule.
    Rivera-Arkoncel ML; Pacquing-Songco D; Lantion-Ang FL
    BMJ Case Rep; 2010 Dec; 2010():. PubMed ID: 22802276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An 88-year-old woman with flushing, alopecia and hirsutism and a Sertoli-Leydig cell tumour.
    Inam ZS; Azizi AH; Holland SW
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29496685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: an identical twin with Sertoli-Leydig cell tumor.
    Cho K; Havelock JC; Gilks B; Dunne C
    Gynecol Endocrinol; 2018 Jul; 34(7):563-566. PubMed ID: 29366348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignant ovarian tumour as cause of virilisation in a 12 year-old girl].
    Vestergård Andersen D; Hermansen MN
    Ugeskr Laeger; 2012 Apr; 174(16):1095-6. PubMed ID: 22510552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sertoli Leydig Cell Tumour Initially Misdiagnosed as Polycystic Ovarian Syndrome and Congenital Adrenal Hyperplasia: A Case Report.
    Paudyal P; Gurung G; Baral J; Kharel N
    JNMA J Nepal Med Assoc; 2020 Nov; 58(231):923-926. PubMed ID: 34506429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
    Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
    Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virilising ovarian tumour: a case associating a Sertoli-Leydig cell tumour and a Brenner tumour.
    Persechini ML; Motton S; Leguevaque P; Donadille F; Escourrou G; Vierasu B; Hamdi S; Bennet A; Caron P
    Gynecol Endocrinol; 2011 May; 27(5):345-50. PubMed ID: 20569103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian tumors secreting androgens: an infrequent cause of hyperandrogenism.
    Perez Lana M; Demayo S; Monastero A; Nolting M
    Minerva Ginecol; 2019 Feb; 71(1):72-77. PubMed ID: 30291701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Androblastoma in a female patient with the signs of virility: a clinical-morphological and genetic study].
    Warenik-Szymankiewicz A; Słopień R; Kedzia H; Kusz K
    Ginekol Pol; 1999 May; 70(5):305-10. PubMed ID: 10462971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sertoli-Leydig cell tumor: a rare ovarian neoplasm. Case report and review of literature.
    Sachdeva P; Arora R; Dubey C; Sukhija A; Daga M; Singh DK
    Gynecol Endocrinol; 2008 Apr; 24(4):230-4. PubMed ID: 18382911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical features and reproductive prognosis of ovarian neoplasms with hyperandrogenemia: a retrospective analysis of 33 cases.
    Shu S; Deng S; Tian JQ; Chen R; Sun JA; Yu Q; Zhu Liu F; Huang LR; Pan YL; Yang XJ; Fan BQ; Liu YH
    Gynecol Endocrinol; 2019 Sep; 35(9):825-828. PubMed ID: 30990090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian steroid cell tumour inducing virilisation in a postmenopausal woman.
    Pinto AM; Martins MB; Oliveira N; Oliveira M
    BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35444026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct in-vivo detection of atypical hormonal expression of a Sertoli-Leydig cell tumour following stimulation with human chorionic gonadotrophin.
    Cohen I; Shapira M; Cuperman S; Goldberger S; Siegal A; Altaras M; Beyth Y
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):491-5. PubMed ID: 8287578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, ultrasonographic, computed tomography and histopathological manifestations of ovarian steroid cell tumour, not otherwise specified: our experience of a rare case with female virilisation and review of the literature.
    Varras M; Vasilakaki T; Skafida E; Akrivis C
    Gynecol Endocrinol; 2011 Jun; 27(6):412-8. PubMed ID: 20586551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review on Sertoli-Leydig Cell Tumours of the Ovary.
    Muscat C; Calleja-Agius J
    Discov Med; 2024 Feb; 36(181):234-247. PubMed ID: 38409829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ovarian gonadal tumors in materials of the clinic of gynecological endocrinology of the Medical Academy in Poznań (1970-1998)].
    Warenik-Szymankiewicz A; Słopień R; Kedzia H; Grotowski W
    Ginekol Pol; 1999 May; 70(5):242-5. PubMed ID: 10462956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of plasma testosterone estimation in the diagnosis of virilizing ovarian neoplasia.
    Hancock KW; Levell MJ; Coulson A
    J Obstet Gynaecol Br Commonw; 1972 Sep; 79(9):846-8. PubMed ID: 4346758
    [No Abstract]   [Full Text] [Related]  

  • 19. Malignant ovarian Sertoli-Leydig cell tumor localized with selective ovarian vein sampling.
    Dunne C; Havelock JC
    J Minim Invasive Gynecol; 2012; 19(6):789-93. PubMed ID: 23084689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sertoli-Leydig cell tumor of the ovary: case study of a 22-year old woman].
    Moussa D; Aziz DA; Niassy DA; Espérence KC; Youssou N; Charles MJ; Alassane D
    Pan Afr Med J; 2016; 25():36. PubMed ID: 28154727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.